Delivery Order SPE2DB20D1100-SPE2DB25FC1B0

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,036.58, is for the delivery of 4,568,038,422 units of the prescription drug Carvedilol ER 20 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,013,166 units of the prescription drug Carvedilol ER 20 mg capsules, with a ceiling value of $2,913.34. The award date is April 23, 2025, and the ultimate completion date is April 24, 2025. This contract is not a set-aside and represents open competition....
This is a $4,239.84 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,366,336 units of the prescription medication Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,176.30 fixed-price contract is for the delivery of 4,565,295,904 units of the drug Carvedilol ER 20 mg capsules. The contract has a period of performance through July 31, 2024. AmerisourceBergen is the prime contractor, and there is no set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up...
This is a $28,552.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 20 mg capsules, a cardiovascular medication, with a period of performance through October 2023. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,715.20, is for the supply of 4,565,840 units of the drug Carvedilol ER 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999, for providing a comprehensive range of medical commodities to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,975.89, is for the delivery of 4,567,908,820 units of the medication Carvedilol ER 10 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. The contract was awarded on April 14, 2025 and does not have a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Carvedilol ER 20 mg capsules. The firm-fixed-price contract, valued at $3,154.94, has an ultimate completion date of July 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,803.56 contract is for the supply of Carvedilol ER 20 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of August 25, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Carvedilol ER 20 mg capsules. The contract has a ceiling value of $1,200.47 and an ultimate completion date of April 3, 2024. This order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 through December 31, 2025. The IDC...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC1B0
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,308.48, is for the supply of 4,568,120,294 units of the prescription medication Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This contract is not set aside for any specific business category. The contract is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, with a ceiling value of $999,999,999.00, which provides a comprehensive global pharmaceutical support to the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026.

Generated 8/3/25, 1:28 AM